Procrit seemed like a biotech
miracle, promising a golden age in medical care. Developed in the 1980s by
Amgen and licensed to the pharmaceutical giant, Johnson & Johnson, the drug
(a.k.a. Epogen and Aranesp) soon generated billions in annual revenue—and still
does. In 2012, world famous cyclist, Olympian, and Tour de France champion
Lance Armstrong was banned from professional cycling on doping charges for
using EPO (the blanket name for the drugs Procrit and Epogen), resulting in a
global controversy about abuse, big pharmaceutical companies, and the lies and
inaccuracies concerning performance-enhancing drugs.
Mark Duxbury was a J&J
salesman who once believed in the blood-booster, setting record sales and
winning company awards. Then Duxbury started to learn unsavory truths about
Procrit and J&J’s business practices. He was fired and filed a
whistleblower suit to warn the public.
When Jan Schlichtman (A Civil Action)
learned of Duxbury’s crusade, he signed on. Now, he’s fighting on behalf of
cancer patients and for every American who trusts Big Pharma with his life. Download and start listening now!